Dr. Jean-Baptiste Belge Presents Powerful Insights On Transforming Care Through Neuromodulation!
Dr. Jean-Baptiste Belge Highlighted Breakthroughs In Neuromodulation During His Keynote At Health 2.0 Conference
Dubai, UAE – July 04, 2025 — The Winter 2024 Edition of the Health 2.0 Conference took place from December 3 to 5, 2024, at the InterContinental DFC in Dubai, UAE. The three-day global health conference brought together experts to explore advancements in medical technology, patient-focused care, and mental health. Among the prominent speakers was Dr. Jean-Baptiste Belge, Director of Neuromodulation at BRAIN-NM Clinics and Professor at the University Hospital of Liège.
Prof. Dr. Belge is an Associate Professor at the University of Liège and Head of Clinic at the University Hospital of Liège, Belgium. He is also a Board Member of the Belgian College of Neuropharmacology and Biological Psychiatry and a member of the Global MRI-ECT Consortium. Prof. Dr. Belge’s passion for advancing the field has earned him recognition from the Royal Academy of Medicine of Belgium.
At the Health 2.0 Conference, Dr. Belge opened his session, titled “Innovations In Neuromodulation And Mental Health,” by demystifying the concept of neuromodulation. He introduced the audience to the life-changing potential of stimulating specific areas of the brain to relieve symptoms of severe psychiatric disorders when conventional treatments are no longer effective. His keynote blended advanced neuroscience with clinical relevance, offering a clear picture of how brain circuit dysfunction contributes to conditions like depression, OCD, PTSD, bipolar disorder, and Alzheimer’s disease.
Dr. Jean presented a range of techniques, including repetitive transcranial magnetic stimulation (rTMS), Theta Burst Stimulation, Deep TMS, and Transcranial Pulse Stimulation (TPS). These non-invasive methods, supported by FDA and CE approvals, are being used at BRAIN-NM Clinics to deliver targeted treatments that are both safe and highly personalized. He also explained how fMRI-based targeting and metaplasticity-enhanced protocols significantly improve patient outcomes in a shorter timeframe than standard medication. At BRAIN-NM Clinics, he leads an interdisciplinary team dedicated to delivering precision neuromodulation therapies that will enhance lives.
Highlighting the future of mental health treatment, the session showcased how advanced neuromodulation protocols, such as SAINT, are achieving up to 90 percent remission by combining high-frequency stimulation with precision targeting. Prof. Dr. Jean-Baptiste Belge emphasized the long-term effectiveness and scalability of these personalized, non-invasive therapies. With established clinics in Belgium and the Netherlands, he also outlined plans for global expansion, underscoring his commitment to integrating neuromodulation into mainstream psychiatric care.
About Health 2.0 Conference
The Health 2.0 Conference brings together healthcare professionals, researchers, policymakers, and technology experts to discuss advancements in medical innovation, patient care, and public health. Hosted in Dubai and Las Vegas, this 3-day global health conference facilitates meaningful dialogue on emerging challenges and solutions across the healthcare landscape. Details of the 2025-26 editions can be found at www.health2conf.com.
